ReViral

Last updated: April 15, 2024

Founder Ken Powell
Founder Ken Powell
Country: UK | Funding: $121M (+)

Website: https://www.reviral.co.uk/

reViral is a biotechnology company that develops drugs to treat Respiratory Syncytial Virus (RSV) infection.